PTPN22 and arthritic joint disease: Arthritic joints from mannan-treated SKG and SKG Ptpn22−/− mice with comparable arthritis scores showed similar levels of cellular infiltrates (data not shown); however, loss of PTPN22 decreased both the likelihood of getting disease and the overall severity of the resulting arthritis (Fig. 4B).